These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28792701)

  • 1. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection.
    Gou Y; Zhao Y; Rao C; Feng S; Wang T; Li D; Tao C
    Clin Lab; 2017 Jul; 63(7):1063-1070. PubMed ID: 28792701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
    Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
    Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
    Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
    Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B.
    Zhang ZQ; Zhang XN; Lu W; Wang YB; Weng QC; Feng YL
    BMC Gastroenterol; 2017 Dec; 17(1):140. PubMed ID: 29202690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection.
    Wu W; Yuan X; Zhang W; Zhou H; Kong X; He Z; Fu T; Zhang W; Jia W; Liang C; Tang H; Wang F; Ye Y; Shao Z; Ji Z
    Front Public Health; 2022; 10():1037508. PubMed ID: 36388269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
    Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
    Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.
    Chan HLY; Yasuda S; Wong GLH; Tada T; Chan CKM; Kumada T; Tse YK; Wong VWS; Toyoda H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2202-2209. PubMed ID: 32293740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critique and systematic review of the clinical utility of hepatitis B core-related antigen.
    Adraneda C; Tan YC; Yeo EJ; Kew GS; Khakpoor A; Lim SG
    J Hepatol; 2023 Apr; 78(4):731-741. PubMed ID: 36586590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
    Zhang ZQ; Shi BS; Lu W; Liu DP; Huang D; Feng YL
    Gastroenterol Hepatol; 2020 Nov; 43(9):526-536. PubMed ID: 32921478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
    Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
    J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues.
    Wang B; Carey I; Bruce M; Montague S; Dusheiko G; Agarwal K
    J Viral Hepat; 2018 Aug; 25(8):886-893. PubMed ID: 29532589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
    Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
    Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers.
    Kuhns MC; Holzmayer V; McNamara AL; Anderson M; Cloherty GA
    Virol J; 2021 Nov; 18(1):235. PubMed ID: 34844619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Hepatitis B Precore/Core-Related Antigens.
    Hong X; Luckenbaugh L; Mendenhall M; Walsh R; Cabuang L; Soppe S; Revill PA; Burdette D; Feierbach B; Delaney W; Hu J
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
    Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
    Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
    Rokuhara A; Tanaka E; Matsumoto A; Kimura T; Yamaura T; Orii K; Sun X; Yagi S; Maki N; Kiyosawa K
    J Viral Hepat; 2003 Jul; 10(4):324-30. PubMed ID: 12823601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
    Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
    World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.